Announcing Dexcel Pharma USA, formerly known as Edenbridge Pharmaceuticals, LLC.
In June 2022, Edenbridge Pharmaceuticals, LLC became a wholly-owned subsidiary of Dexcel Pharma. Dexcel Pharma is the largest private pharmaceutical company in Israel, commercializing an extensive portfolio of branded and generic drugs in Israel and various countries...
Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC is pleased to announce the launch of Pantoprazole Sodium for Delayed-Release Oral Suspension, a generic version of Protonix®* for delayed-release oral suspension. Pantoprazole Sodium for Delayed-Release Oral...
Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC is pleased to announce the launch of Isosorbide Mononitrate Extended-Release Tablets, USP, a generic version of Imdur Extended-Release Tablets. Isosorbide Mononitrate Extended-Release Tablets, USP, are indicated...
Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC is pleased to announce the launch of two new molecules into the U.S. market: Diclofenac Sodium Extended-Release Tablets, USP, a generic version of Voltaren®*-XR Tablets and Venlafaxine Extended-Release Tablets....
Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC is pleased to announce the launch of Vigabatrin Tablets USP, 500mg, a generic version of Sabril®* Tablets, 500mg. Vigabatrin Tablets USP, 500mg are indicated as adjunctive therapy for refractory complex partial...
Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC announces that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Prednisolone Sodium Phosphate Oral Solution to include the 15 mg Prednisolone...
Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC announces that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Amantadine Hydrochloride Tablets, 100mg, a generic version of Symmetrel®*...
Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC announces that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Doxepin Hydrochloride Capsules USP, 150mg, a generic version of Sinequan...
Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC today announced that DARTISLA ODT (glycopyrrolate) is now available by prescription in the United States through Phil, the commercialization partner and eHub for DARTISLA ODT, as well as in retail pharmacies...
Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC today announced that it has received approval from the U.S. Food and Drug Administration on its 505(b)(2) New Drug Application (NDA) for DARTISLA ODT (glycopyrrolate) orally disintegrating tablets. DARTISLA ODT...